Body

How to make stronger, 'greener' cement

CAMBRIDGE, Mass--Concrete is the world's most-used construction material, and a leading contributor to global warming, producing as much as one-tenth of industry-generated greenhouse-gas emissions. Now a new study suggests a way in which those emissions could be reduced by more than half — and the result would be a stronger, more durable material.

BUSM researchers find NAS treatment needs standardization

(Boston) – When it comes to treating infants with neonatal abstinence syndrome (NAS), researchers from Boston University School of Medicine (BUSM) believe the care for these infants should be consistent and objective, with standardized assessment tools and evidence to back up pharmacologic and nonpharmacologic treatment choices.

The review paper, which is published online in Addiction Science & Clinical Practice, highlights the need for more research in this field to optimize care for both infants and their mothers.

Fecal microbiota transplantation recommended for treatment of C. difficile

(Vienna, October 26, 2014) The transplantation of faecal microbiota from a healthy donor has been shown in recent clinical studies to be a safe and highly effective treatment for recurrent Clostridium difficile (C. difficile) infection and is now recommended in European treatment guidelines.1,2 Faecal microbiota transplantation (FMT) has emerged as a revolutionary, potentially life-saving treatment for this common, difficult-to-treat infection, and is showing promise in the management of other microbiota-related conditions.3,4

Researchers engineer 'Cas9' animal models to study disease and inform drug discovery

Cambridge, MA, September 25, 2014 — Researchers from the Broad Institute and Massachusetts Institute of Technology have created a new mouse model to simplify application of the CRISPR-Cas9 system for in vivo genome editing experiments. The researchers successfully used the new "Cas9 mouse" model to edit multiple genes in a variety of cell types, and to model lung adenocarcinoma, one of the most lethal human cancers. The mouse has already been made available to the scientific community and is being used by researchers at more than a dozen institutions.

Modified vitamin D shows promise as treatment for pancreatic cancer

Sherman, Evans and their collaborators focused their attention on one component of this wall: pancreatic stellate cells, which usually respond to small injuries by briefly switching to an activated state, spurring new cell growth. In the case of cancer, however, the stellate cells near a tumor—in response to signals from the tumor—are constantly turned on.

Super enhancers in the inflamed endothelium

Boston, MA – Normally, the lining of blood vessels, or endothelium, when at rest, acts like Teflon, ignoring the many cells and other factors rushing by in the bloodstream. In response to inflammatory signals, as well as other stimuli, endothelial cells change suddenly and dramatically—sending out beacons to attract inflammatory cells, changing their surface so those cells can stick and enter tissues, and initiating a complex cascade of responses essential to fighting infection and dealing with injury.

Novel compound prevents metastasis of multiple myeloma in mouse studies

BOSTON –– In an advance against the problem of cancer metastasis, Dana-Farber Cancer Institute scientists have shown that a specially developed compound can impede multiple myeloma from spreading to the bones in mice. The findings, published in the Sept. 25 issue of Cell Reports, suggest the technique can protect human patients, as well, from one of the most deadly aspects of cancer.

Dinosaur family tree gives fresh insight into rapid rise of birds

The most comprehensive family tree of meat-eating dinosaurs ever created is enabling scientists to discover key details of how birds evolved from them.

The study has shown that the familiar anatomical features of birds – such as feathers, wings and wishbones – all first evolved piecemeal in their dinosaur ancestors over tens of millions of years.

New protein players found in key disease-related metabolic pathway

CAMBRIDGE, Mass. (September 25, 2014) – To coordinate their size and growth with current environmental conditions, cells rely on the mechanistic target of rapamycin complex 1 (mTORC1) pathway, which senses cellular stresses, growth factors, and the availability of nutrients, such as amino acids and glucose.

Large study pinpoints synapse genes with major roles in severe childhood epilepsies

An international research team has identified gene mutations causing severe, difficult-to-treat forms of childhood epilepsy. Many of the mutations disrupt functioning in the synapse, the highly dynamic junction at which nerve cells communicate with one another.

Protein controlling gut's protective force field identified

Scientists have identified a protein in the human intestine that helps to protect against attack from opportunistic bacteria that strike when our defences are down. The protein receptor is activated during illness, producing a force field on the gut's surface made of a sugary substance that encourages the growth of protective bacteria.

NYU Langone scientists identify key factor that maintains stem cell identity

NEW YORK, September 25, 2014— A protein implicated in several cancers appears to play a pivotal role in keeping stem cells in an immature "pluripotent" state, according to a new study by NYU Langone Medical Center scientists. The study is published online today in Cell Reports.

Stem cells are the perpetual adolescents of the cellular world, uncommitted to any cell fate. In principle, they can be programmed to differentiate into any mature cell type, holding the promise of regenerating tissues and organs. A fuller understanding of their biology, however, is needed.

Surprising diversity of antibody family provides clues for HIV vaccine design

LA JOLLA, CA—September 25, 2014—Scientists at The Scripps Research Institute (TSRI) have described how a single family of antibodies that broadly neutralizes different strains of HIV has evolved remarkably diverse structures to attack a vulnerable site on the virus. The findings provide clues for the design of a future HIV vaccine.

"In a sense, this antibody family takes more than one shot on goal in order to hit divergent forms of HIV," said Ian A. Wilson, the Hansen Professor of Structural Biology and member of the Skaggs Institute for Chemical Biology at TSRI.

New genes identified with key role in the development of severe childhood epilepsies

In the largest collaborative study so far, an international team of researchers, including scientists from VIB and Antwerp University identified novel causes for severe childhood epilepsies. The researchers analyzed the genetic information of 356 patients and their parents. In their analysis, the research teams looked for genes that had acquired new mutations in the children with severe epilepsies when compared to the DNA of the parents. In total, they identified 429 new mutations and in 12% of children, these mutations were considered unequivocally causative for the patient's epilepsy.

How the ends of chromosomes are maintained for cancer cell immortality